BridgeBio Pharma (BBIO) shares outstanding

Shares outstanding · fiscal 2025
191.53M

BridgeBio Pharma (BBIO) had 191.53M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.9% higher than the 186.08M of fiscal 2024. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
191.53M
Change on fiscal 2024
+2.9%
Growth, 5 years
+10.2% a year
Highest on record
191.53Mfiscal 2025
Lowest on record
118.00Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

BridgeBio Pharma shares outstanding, in more detail

The market data feed counts 194.80M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 10.2% a year. Across the 6 fiscal years on record (2020–2025), the highest was 191.53M in fiscal 2025 and the lowest 118.00M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

BridgeBio Pharma shares outstanding, year by year

BridgeBio Pharma (BBIO) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025191.53M 2.9% up
2024186.08M 14.3% up
2023162.79M 10.4% up
2022147.47M 2.2% up
2021144.36M 22.3% up
2020118.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of BridgeBio Pharma and comparable companies
CompanyShares outstandingFiscal year
ICON ICLR79.09M2025
Jazz Pharmaceuticals JAZZ60.98M2025
Solventum SOLV175.30M2025
BridgeBio Pharma BBIO191.53M2025
Glaukos GKOS57.19M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma shares outstanding: questions and answers

How many shares does BridgeBio Pharma have?

BridgeBio Pharma (BBIO) had 191.53M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.9% higher than the 186.08M of fiscal 2024. The market data feed counts 194.80M shares outstanding today.

What is the growth rate of BridgeBio Pharma's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 10.2% a year.

What are the highest and lowest diluted share count figures on record for BridgeBio Pharma?

Across the 6 fiscal years on record (2020–2025), the highest was 191.53M in fiscal 2025 and the lowest 118.00M in fiscal 2020.

How is BridgeBio Pharma's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For BridgeBio Pharma it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.